Infertility now affects one in six people globally, bringing with it an emotional, physical, and financial toll. The path to diagnosis can stretch on for years, and treatment plans often feel impersonal. But Enhanced Fertility, a UK-Portugal healthtech startup, is on a mission to change that—with AI, empathy, and speed. The company is preparing to raise €2 million in June to scale its platform, accelerate U.S. entry, and expand across Europe.
The team behind Enhanced Fertility has created a powerful AI platform that cuts diagnosis time from over three years to just 30 days. Through a combination of at-home fertility testing and intelligent diagnostics trained on over 1.4 million anonymized patient records, they deliver fast, personalised treatment options. Their solution is already showing impact—30 babies have been born with their help in just 18 months.
Cutting Fertility Diagnosis from Years to Days
Co-founded by Andreia Trigo and Frank Khan Sullivan, Enhanced Fertility began as a personal mission. Andreia was diagnosed with infertility at just 17, a life-changing event that later inspired her to become a nurse and TEDx speaker. That experience, combined with Frank’s background in data science, led to the birth of Enhanced Fertility.
Trigo says she remembers the pain of her diagnosis vividly—and it’s that memory that drives their goal: to make fertility care faster, more affordable, and deeply personalised. Their platform, EnhancedDx, is the result of years of development and real-world testing. By combining more than 100 at-home tests with AI-powered risk assessment tools, the platform offers tailored care in record time.
Rather than relying on one-size-fits-all treatments, the platform evaluates medical results, emotional well-being, diet, exercise, and even mental health to craft a comprehensive plan. As Sullivan puts it, “A 25-year-old cancer survivor and a 40-year-old going through multiple IVF cycles need very different support. That’s why personalisation is key.”
Enhanced Fertility’s Vision: Redefining Reproductive Healthcare
With IVF success rates hovering around 30% per cycle, many couples face heartbreak and high costs. Enhanced Fertility wants to tilt those odds by offering smarter care from the start. Their platform uses seven machine learning models working in tandem to interpret patient data—everything from lab results to lifestyle choices. The AI compares each case to a database of over a million patient records and returns insights in just seconds.
But they’re not replacing doctors. The system always keeps clinicians in the loop, offering support—not substitution. Patients receive a “Patients Like Me” report, an intelligent breakdown that matches their profile with similar cases and proven treatment outcomes.
Their approach is GDPR-first, with strong data privacy at its core. Sullivan explains they built the system with NHS digital frameworks as a minimum standard, going even further to ensure trust and data safety—vital for any healthcare innovation dealing with sensitive data over long periods.
Already working with more than 20 private hospitals and clinics, Enhanced Fertility is now running a public health pilot with Hospital de Braga in Portugal. The startup has grown from two to eight team members and continues to see 30% month-over-month revenue growth. Now, they’re preparing to scale operations, raise €2 million, and bring their AI fertility diagnostics to more families worldwide.
From Fertility to Broader Healthcare Impact
The ambition doesn’t stop at helping couples conceive. The founders see their Enhanced Diagnostics engine as a breakthrough technology that could expand into chronic care fields like diabetes and cardiovascular medicine. The platform’s power lies in its ability to personalize care using millions of data points, giving doctors and patients clearer, faster, and more effective treatment pathways.
Looking ahead, the company’s vision is bold: help bring one million babies into the world while transforming the fertility journey from slow and stressful to smart and supportive. Sullivan says the team will stay laser-focused on clinical outcomes as they explore new healthcare verticals.
With plans to enter the U.S.—the world’s largest fertility market—and expand across Europe, Enhanced Fertility is poised to be a major player in next-generation reproductive care. The fusion of data science and human empathy is unlocking new hope for families. And if the founders succeed, their platform could soon power the birth of not just babies—but a whole new standard of care.
